| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 167.44B | 162.93B | 158.25B | 140.94B | 116.31B | 92.97B |
| Gross Profit | 17.05B | 14.97B | 13.48B | 10.07B | 7.21B | 6.13B |
| EBITDA | 16.54B | 15.10B | 15.09B | 12.93B | 9.50B | 10.35B |
| Net Income | -2.40B | -2.89B | -7.70B | -84.00M | -5.19B | -2.84B |
Balance Sheet | ||||||
| Total Assets | 130.46B | 134.09B | 131.76B | 137.07B | 131.30B | 132.22B |
| Cash, Cash Equivalents and Short-Term Investments | 12.76B | 13.55B | 12.32B | 12.99B | 9.36B | 12.25B |
| Total Debt | 36.84B | 41.01B | 40.94B | 44.37B | 43.62B | 46.53B |
| Total Liabilities | 80.11B | 82.10B | 80.15B | 80.29B | 77.73B | 76.59B |
| Stockholders Equity | 50.34B | 51.99B | 51.62B | 56.65B | 53.57B | 55.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 432.00M | 5.20B | 839.00M | -989.00M | -3.89B |
| Operating Cash Flow | 0.00 | 15.31B | 18.32B | 10.73B | 8.26B | 7.94B |
| Investing Cash Flow | 0.00 | -12.89B | -13.94B | -6.33B | -6.08B | -11.57B |
| Financing Cash Flow | 0.00 | -1.04B | -5.95B | -1.53B | -5.10B | 11.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥13.95B | 8.89 | ― | 4.93% | 3.19% | 1.83% | |
78 Outperform | ¥10.62B | 7.66 | ― | 3.48% | 0.24% | 20.23% | |
69 Neutral | ¥6.39B | -102.51 | ― | 1.06% | 6.41% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥15.57B | 4.33 | ― | 2.87% | 2.38% | -5.80% | |
54 Neutral | ¥22.82B | 3.53 | ― | 4.33% | 5.12% | ― | |
45 Neutral | ¥8.13B | -73.23 | ― | ― | -19.32% | -171.53% |